Skip to main content

Table 2 Comparison of study population by follow-up period

From: Time to follow up after an abnormal finding in organized gastric cancer screening in Korea

Variables

 

Follow-up time <90 days

Follow-up time ≥90 days

 
  

Number (%)

P -value

Total

 

2059 (86.1)

332 (13.9)

 

Age

40–49

328 (91.1)

32 (8.9)

<0.0001

 

50–59

544 (89.6)

63 (10.4)

 
 

60–69

806 (85.5)

137 (14.5)

 
 

70+

381 (79.2)

100 (20.8)

 

Sex

Male

1418 (86.4)

223 (13.6)

0.5356

 

Female

641 (85.5)

109 (14.5)

 

Result

Suspicion of cancer

397 (59.4)

271 (40.6)

<0.0001

 

Cancer

1662 (96.5)

61 (3.5)

 

Health Insurance

Medical Aids

103 (71.0)

42 (29.0)

<0.0001

 

NHI premium in the lower 50%

860 (90.2)

94 (9.9)

 
 

NHI premium in the upper 50%

1096 (84.8)

196 (15.2)

 

Method

UGIS

235 (58.6)

166 (41.4)

<0.0001

 

EGD

1824 (91.7)

166 (8.3)

 

Symptom

    

Fatigue

No

1708 (86.2)

273 (13.8)

0.7454

 

Yes

351 (85.6)

59 (14.4)

 

Abdominal pain and discomfort

No

1449 (84.6)

263 (15.4)

0.0009

 

Yes

610 (89.8)

69 (10.2)

 

Abdominal bloating

No

1783 (85.6)

300 (14.4)

0.0573

 

Yes

276 (89.6)

32 (10.4)

 

Indigestion

No

1807 (85.9)

297 (14.1)

0.3774

 

Yes

252 (87.8)

35 (12.2)

 

Changes in bowel habits

No

1805 (86.2)

289 (13.8)

0.7523

 

Yes

254 (85.5)

43 (14.5)

 

Weight loss

No

1966 (86.1)

317 (13.9)

0.9991

 

Yes

93 (86.1)

15 (13.9)